ERYTHROMYCINE PANPHARMA 500 mg, powder for concentrate for infusion 10 bottles
Active ingredients: Erythromycin lactobionate, Erythromycin
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for concentrate for infusion10 bottlesintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ERYTHROMYCINE PANPHARMA 500 mg, poudre pour solution à diluer pour perfusion
- Pharmaceutical form
- poudre pour solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre de 500 mg
- Marketing authorisation holder
- PANPHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Jan 2018
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68664794CIP75502371CIP133400955023715Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉRYTHROMYCINEpoudre | 500 mg · un flacon | FT |
| LACTOBIONATE D'ÉRYTHROMYCINEpoudre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.